It decreases hunger and makes you feel full sooner, aiding in portion control and reducing calorie intake
It's an investigational drug currently in Phase 3 clinical trials Eli Lilly's TRIUMPH Phase 3 program includes multiple trials for obesity, type 2 diabetes, NASH, and cardiovascular outcomes Expected timeline: FDA submission in 2026, potential approval in 20272028 Phase 2 results showed 24.2% weight loss at 48 weeks, the highest ever recorded for a GLP-1 class medication How to access now: Clinical trial enrollment (free), compounding pharmacies (with important legal caveats), or research peptides (grey market) When approved, retatrutide will be the first triple-agonist obesity medication (GLP-1 + GIP + glucagon) Is Retatrutide FDA Approved
The result: targeted visceral fat loss without the side effects of injecting growth hormone directly
84 WangD
Then, during the bonding appointment, the tray helps transfer the brackets to the teeth
How much weight loss is needed to reduce joint pain